{"filing":{"accession_number":"0001193125-26-389291","cik":"0001572616","ticker":"GUTS","company_name":"FRACTYL HEALTH, INC.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-09-10","primary_document":"guts-20260910.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526389291/guts-20260910.htm"},"events":[{"id":32945,"run_id":30287,"accession_number":"0001193125-26-389291","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Fractyl Health received a delisting notice from Nasdaq on September 10, 2026, after failing to maintain the minimum bid price of $1.00 per share for 30 consecutive business days and not regaining compliance within the 180-day grace period. The company intends to request a hearing before a Nasdaq Hearings Panel to stay delisting, and has filed a proxy statement seeking stockholder approval for a reverse stock split to regain compliance. This is a clear and material delisting risk disclosure under Item 3.01.","company_name":"FRACTYL HEALTH, INC.","ticker":"GUTS","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36243,"accession_number":"0001193125-26-389291","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Fractyl Health received a delisting notice from Nasdaq on September 10, 2026, after failing to maintain the minimum bid price of $1.00 per share for 30 consecutive business days and not regaining compliance within the 180-day grace period. The company intends to request a hearing before a Nasdaq Hearings Panel to stay delisting, and has filed a proxy statement seeking stockholder approval for a reverse stock split to regain compliance. This is a clear and material delisting risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:16:50.622500+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36243,"accession_number":"0001193125-26-389291","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Fractyl Health received a delisting notice from Nasdaq on September 10, 2026, after failing to maintain the minimum bid price of $1.00 per share for 30 consecutive business days and not regaining compliance within the 180-day grace period. The company intends to request a hearing before a Nasdaq Hearings Panel to stay delisting, and has filed a proxy statement seeking stockholder approval for a reverse stock split to regain compliance. This is a clear and material delisting risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:16:50.622500+00:00","company_name":"FRACTYL HEALTH, INC.","ticker":"GUTS","filing_date":"2026-09-11"}]}